Glomethasone 8 mg 2 ml 3 Amp 6224000821609

Glomethasone 8 mg 2 ml 3 Amp 6224000821609

Description:

Glomethasone 8 mg/2 ml is a prescription injectable corticosteroid medicine containing betamethasone disodium phosphate, manufactured by Global Pharmaceutical Industries. It is supplied as 3 sterile ampoules for intramuscular (i.m.) injection, slow intravenous (i.v.) injection, or i.v. infusion. This systemic corticosteroid is used for the rapid control of severe inflammatory and allergic conditions, as well as certain rheumatic, dermatologic, respiratory, and other immune-mediated disorders when oral therapy is not suitable or when a fast onset of action is required. It must be used under strict medical supervision in hospital or clinic settings.

Indications:

• Management of severe acute allergic reactions (e.g., severe asthma exacerbations, drug hypersensitivity reactions, serum sickness) as part of emergency treatment.
• Treatment of severe inflammatory and immune-mediated conditions when parenteral corticosteroid therapy is indicated (e.g., severe rheumatoid arthritis flare, acute gouty arthritis, severe psoriasis or dermatitis).
• Adjunctive therapy in certain severe respiratory conditions such as acute exacerbations of bronchial asthma or chronic obstructive pulmonary disease (COPD), as directed by a physician.
• Short-term treatment of acute adrenal insufficiency or situations requiring high-dose corticosteroids when oral administration is not possible.
• Other conditions responsive to systemic corticosteroids where rapid effect is required and parenteral administration is preferred, as determined by the treating physician.

Active Ingredients / Key Components:

• Betamethasone disodium phosphate – 8 mg per 2 ml ampoule (concentration: 4 mg/ml). This is a potent synthetic glucocorticoid with strong anti-inflammatory and immunosuppressive properties.
• Inactive ingredients (excipients): Specific excipients used in the solution (e.g., buffers, stabilizers, solvents) are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Full excipient list should be obtained from the official package insert.

Dosage & Administration / How to Use:

• Route of administration: For intramuscular (i.m.) injection, slow intravenous (i.v.) injection, or i.v. infusion only. Do not administer intrathecally or epidurally.
• Dosage: The exact dose, frequency, and duration are determined by the physician based on the condition being treated, severity of symptoms, and patient response. Typical practice involves using the lowest effective dose for the shortest possible duration.
• Adults: Dose is individualized. In acute severe conditions, a single or divided dose may be given by slow i.v. injection or infusion, or deep i.m. injection, followed by adjustment according to clinical response.
• Children: Pediatric dosing must be carefully adjusted by a specialist according to body weight, age, and disease severity. Use in children requires particular caution due to risk of growth suppression and other systemic effects.
• Administration technique: Injection must be performed by qualified healthcare professionals using aseptic technique. For i.v. use, administer slowly as recommended in the official prescribing information or dilute in compatible infusion fluid as directed.
• Tapering: For prolonged therapy, corticosteroid doses should not be stopped abruptly. Gradual dose reduction is required to avoid adrenal insufficiency, as instructed by the physician.
• Do not self-inject or adjust the dose without medical advice. Always follow the doctor’s instructions and the official product leaflet.

Clinical Benefits:

• Provides rapid and potent anti-inflammatory action, helping to quickly reduce swelling, redness, and pain in severe inflammatory conditions.
• Offers strong immunosuppressive effects, aiding in the control of acute allergic and immune-mediated reactions when fast systemic corticosteroid therapy is needed.
• Useful as an injectable alternative when oral corticosteroids cannot be used (e.g., vomiting, unconsciousness, perioperative settings).
• Supports stabilization of patients with severe asthma attacks or other acute respiratory exacerbations as part of comprehensive emergency management.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to betamethasone, other corticosteroids, or any component of the formulation.
• Generally contraindicated in systemic fungal infections and untreated severe infections unless specific anti-infective therapy is in place and benefits outweigh risks.
• Use with extreme caution in patients with diabetes mellitus, hypertension, heart failure, peptic ulcer disease, osteoporosis, glaucoma, cataracts, psychiatric disorders, or a history of tuberculosis.
• Long-term or high-dose corticosteroid therapy may cause adrenal suppression, Cushingoid features, increased infection risk, bone loss, and metabolic disturbances.
• May mask signs of infection and reduce resistance to new infections; monitor closely for fever, sore throat, or other infection symptoms.
• Use during pregnancy and breastfeeding only if clearly needed and prescribed by a physician after careful risk–benefit assessment.
• Live vaccines should generally be avoided during systemic corticosteroid therapy at immunosuppressive doses.
• Patients with liver or kidney impairment, elderly patients, and children require special monitoring and possible dose adjustment.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as diabetes, hypertension, heart disease, liver disease, kidney disease, osteoporosis, or eye problems.
• Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s prescription and supervision.
• Keep out of reach of children.
• Use only as directed by a healthcare professional. Do not share this medication with others.

Side Effects:

• Common side effects (especially with repeated or high doses) may include increased appetite, weight gain, fluid retention, elevated blood pressure, mood changes (e.g., irritability, euphoria), difficulty sleeping, and increased blood glucose levels.
• Long-term use may lead to Cushingoid appearance (moon face, central obesity), thinning of the skin, easy bruising, acne, delayed wound healing, muscle weakness, osteoporosis, and menstrual irregularities.
• Serious side effects can include severe allergic reactions, vision changes, eye pain, severe abdominal pain or black/tarry stools (possible gastrointestinal bleeding), severe mood or behavioral changes, signs of infection (fever, chills, persistent sore throat), or symptoms of adrenal insufficiency (extreme fatigue, dizziness, fainting).
• Seek immediate medical attention if you experience difficulty breathing, swelling of the face or throat, severe rash, sudden vision loss, chest pain, or any other alarming symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Protect from excessive heat and freezing. Keep ampoules in the original packaging until use. Do not use if the solution is discolored, contains particles, or if the ampoule is damaged. Keep container tightly closed where applicable. Keep out of reach of children.

Specifications:

• Product form: Sterile injectable solution in ampoules.
• Strength: 8 mg betamethasone disodium phosphate per 2 ml ampoule (4 mg/ml).
• Pack size: 3 ampoules per pack.
• Route of administration: i.m. injection, slow i.v. injection, or i.v. infusion by healthcare professionals only.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.